Skip to content

Clinical trials

Phase 2/3 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20071
20111
20121
20151
20161
20191
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Solvay Pharmaceuticals2
All India Institute of Medical Sciences1
Bristol-Myers Squibb1
Dhurakij Pundit University1
Prof. Tony hayek MD1
University of Guadalajara1
VA Office of Research and Development1
Veloxis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias11
Hypertriglyceridemia3
Hyperlipidemias2
Obesity2
Atherosclerosis1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Glucose Metabolism Disorders1
Hypercholesterolemia1
Hypertension1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.